"If you look back around 18 months to two years you will notice they were touting 2 new deals and cash sustainability by around about now."
Andrew you've still offered a pretty watered down version lol
If you really go back to the company following it's prestated guidance then by the end of next month it should actually be 5 new deals & cash sustainability - if following the 3 new deals each calender year there's 2 deal overhang from 2011 & 3 deals for 2012. Of course guidance is never certain but if you go back to the start of 2011 & with the very encouraging feat of 3 deals in prior 12 months (which i guess gave them their guidance of repeating) then by this point Phylogica should have 9 big pharma deals under the banner (VS 4 currently) & cash sink dissappeared with a profitable business enterprise.
Actually if you look back to that same point in 2011 i think the company going by presentations should of been aquired by now for in excess of $250M.... not issuing convertible notes with a $11M market cap.
Really not trying to grind the axe but when there's very little to talk about beside the ahhh not much that's happening what else to do but a history lesson.
One day one day :-)
PYC Price at posting:
2.2¢ Sentiment: None Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)